Lucid Diagnostics Inc.
LUCD
$1.26
$0.086.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 40.46% | -30.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 40.46% | -30.83% | |||
| Cost of Revenue | 0.77% | -27.69% | |||
| Gross Profit | 44.67% | 23.73% | |||
| SG&A Expenses | -5.93% | 5.99% | |||
| Depreciation & Amortization | 850.00% | -106.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.77% | -1.17% | |||
| Operating Income | 8.83% | -1.72% | |||
| Income Before Tax | 83.50% | -133.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 83.50% | -133.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 83.50% | -133.15% | |||
| EBIT | 8.83% | -1.72% | |||
| EBITDA | 9.00% | -1.76% | |||
| EPS Basic | 84.78% | -164.80% | |||
| Normalized Basic EPS | 36.94% | -40.77% | |||
| EPS Diluted | 84.78% | -164.80% | |||
| Normalized Diluted EPS | 36.94% | -40.77% | |||
| Average Basic Shares Outstanding | 43.89% | 17.85% | |||
| Average Diluted Shares Outstanding | 43.89% | 17.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||